Life Sciences Times

Waters Launches BD FACSDiscover A7 Cell Analyzer for Spectral Flow Cytometry

Q32 Bio Appoints José Trevejo Chief Medical Officer and Ellie Hershberger Chief Development Officer

FDA Approves Scholar Rock’s Isembyld for Spinal Muscular Atrophy

Zipalertinib Plus Chemotherapy Improves Progression-Free Survival in EGFR-Mutant Lung Cancer Trial

Enhertu Improves Progression-Free Survival in HER2-Mutant Lung Cancer Phase 3 Trial

FDA Accepts Takeda’s Zasocitinib NDA for Priority Review in Plaque Psoriasis

Lysoway Therapeutics Reports Preclinical Data for TRPML1 Agonist LW-1017

Vyome Appoints Jerry Leonard as Chief Financial Officer

Biomunex Says FDA Review Completed for IPN60330 Ahead of Phase 1 Trial

SonoThera Names Adam J. Shaywitz Chief Medical Officer